000 | 01804 a2200529 4500 | ||
---|---|---|---|
005 | 20250513142625.0 | ||
264 | 0 | _c19980522 | |
008 | 199805s 0 0 eng d | ||
022 | _a0042-6822 | ||
024 | 7 |
_a10.1006/viro.1998.9079 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGünther, S | |
245 | 0 | 0 |
_aAnalysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity. _h[electronic resource] |
260 |
_bVirology _cApr 1998 |
||
300 |
_a146-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aDNA, Viral |
650 | 0 | 4 |
_aEpitopes, B-Lymphocyte _ximmunology |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aGenetic Variation |
650 | 0 | 4 | _aGenome, Viral |
650 | 0 | 4 |
_aHepatitis B _xdrug therapy |
650 | 0 | 4 |
_aHepatitis B Antibodies _ximmunology |
650 | 0 | 4 |
_aHepatitis B Core Antigens _xgenetics |
650 | 0 | 4 |
_aHepatitis B e Antigens _xgenetics |
650 | 0 | 4 |
_aHepatitis B virus _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInterferon alpha-2 |
650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 | _aVirus Replication |
700 | 1 | _aPaulij, W | |
700 | 1 | _aMeisel, H | |
700 | 1 | _aWill, H | |
773 | 0 |
_tVirology _gvol. 244 _gno. 1 _gp. 146-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/viro.1998.9079 _zAvailable from publisher's website |
999 |
_c9548611 _d9548611 |